David Margolin

121 papers receiving 3.9k citations

David Margolin's Hit Papers

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial 2012 · 883 citations
8830+4+9Years since publication250500750

Peers

David Margolin
Comparison fields: 5 of 97
  • Pathology and Forensic Medicine 2.8k
  • Neurology 1.1k
  • Rheumatology 831
  • Immunology 1.1k
  • Oncology 1.2k
Replace John R. Corboy with:
John R. Corboy United States
Anders Svenningsson Sweden
Jan Lycke Sweden
Katherine Miszkiel United Kingdom
Irina Elovaara Finland
Allan G. Kermode Australia
Bibiana Bielekova United States
Andreas Bitsch Germany
Florian Deisenhammer Austria
Nitin J. Karandikar United States
David Margolin relative to John R. Corboy United States John R. Corboy's profile →
Citations per field
00.5×1.5×2.2×
John R. Corboy · 1×
Citations per year

Countries citing papers authored by David Margolin

Since Specialization
Citations

This map shows the geographic impact of David Margolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Margolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Margolin more than expected).

Fields of papers citing papers by David Margolin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Margolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Margolin. The network helps show where David Margolin may publish in the future.

Co-authors

The 25 scholars most cited alongside David Margolin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Margolin Line = papers co-authored together David Margolin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
Hit paper breakdown →
2012884
2
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
Hit paper breakdown →
2012883
3 2017212
4 2012193
5 2017176
6 2010125
7 2003115
8 2013111
9 2011101
10 199890
11 201179
12 198478
13 201860
14 200244
15 198443
16 198436
17 201934
18 202134
19 199733
20 201533

About David Margolin

David Margolin is a scholar working on Pathology and Forensic Medicine, Rheumatology, Immunology, Neurology and Oncology, having authored 125 papers that have together received 4.0k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (69 papers), Rheumatoid Arthritis Research and Therapies (20 papers), Polyomavirus and related diseases (15 papers), Immunotherapy and Immune Responses (14 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Peripheral Neuropathies and Disorders (13 papers), Acute Lymphoblastic Leukemia research (12 papers) and Systemic Lupus Erythematosus Research (10 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.8k citations), Neurology (1.1k citations), Rheumatology (831 citations), Immunology (1.1k citations) and Oncology (1.2k citations). David Margolin has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Alasdair Coles, Krzysztof Selmaj, Edward Fox, D. A. S. Compston, Eva Havrdová, Douglas L. Arnold, Stephen Lake, Jeffrey Cohen, Michael Panzara and Howard L. Weiner. Their work appears in journals such as Neurology, Multiple Sclerosis Journal, Journal of the Neurological Sciences, Multiple Sclerosis and Related Disorders and Journal of Neurology Neurosurgery & Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact